Total Payments
$16,512
2024 Payments
$14,293
Companies
24
Transactions
167
Medicare Patients
826
Medicare Billing
$117,306
Payment Breakdown by Category
Other$9,380 (56.8%)
Food & Beverage$3,778 (22.9%)
Travel$3,334 (20.2%)
Education$20.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,380 | 3 | 56.8% |
| Food and Beverage | $3,778 | 152 | 22.9% |
| Travel and Lodging | $3,334 | 11 | 20.2% |
| Education | $20.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $14,012 | 49 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $620.70 | 35 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $483.30 | 25 | $0 (2024) |
| ABBVIE INC. | $317.09 | 13 | $0 (2024) |
| Boston Scientific Corporation | $152.23 | 1 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $143.25 | 7 | $0 (2024) |
| Madrigal Pharmaceuticals | $126.35 | 4 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $100.96 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $100.23 | 5 | $0 (2023) |
| Ipsen Biopharmaceuticals, Inc | $86.73 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,293 | 64 | Gilead Sciences, Inc. ($13,641) |
| 2023 | $758.98 | 39 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($273.90) |
| 2022 | $590.06 | 20 | ABBVIE INC. ($175.88) |
| 2021 | $64.73 | 4 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($31.62) |
| 2020 | $183.09 | 8 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($62.86) |
| 2019 | $186.01 | 11 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($72.64) |
| 2018 | $214.01 | 8 | Gilead Sciences, Inc. ($142.41) |
| 2017 | $221.63 | 13 | AbbVie, Inc. ($71.06) |
All Payment Transactions
167 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.03 | General |
| 12/11/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $34.66 | General |
| Category: LIVER DISEASE | ||||||
| 11/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.62 | General |
| 11/12/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Rare Disease | ||||||
| 11/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.74 | General |
| 11/01/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,070.00 | General |
| Category: INFLAM | ||||||
| 10/31/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Travel and Lodging | In-kind items and services | $237.85 | General |
| Category: INFLAM | ||||||
| 10/31/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: INFLAM | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Travel and Lodging | In-kind items and services | $72.00 | General |
| Category: INFLAM | ||||||
| 10/30/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Travel and Lodging | In-kind items and services | $10.72 | General |
| Category: INFLAM | ||||||
| 10/30/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Travel and Lodging | In-kind items and services | $10.11 | General |
| Category: INFLAM | ||||||
| 10/30/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: INFLAM | ||||||
| 10/30/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $9.80 | General |
| Category: INFLAM | ||||||
| 10/29/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Travel and Lodging | In-kind items and services | $1,173.28 | General |
| Category: INFLAM | ||||||
| 10/29/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $115.65 | General |
| Category: INFLAM | ||||||
| 10/24/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $33.93 | General |
| Category: LIVER DISEASE | ||||||
| 10/23/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,070.00 | General |
| Category: INFLAM | ||||||
| 10/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $85.90 | General |
| 10/21/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Travel and Lodging | In-kind items and services | $232.58 | General |
| Category: INFLAM | ||||||
| 10/21/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $122.11 | General |
| Category: INFLAM | ||||||
| 10/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.44 | General |
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 213 | 318 | $107,564 | $26,474 |
| 2022 | 6 | 171 | 303 | $102,519 | $24,300 |
| 2021 | 6 | 221 | 368 | $130,399 | $31,293 |
| 2020 | 6 | 221 | 458 | $150,415 | $35,239 |
Total Patients
826
Total Services
1,447
Medicare Billing
$117,306
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 29 | 104 | $36,920 | $9,877 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 59 | 74 | $19,906 | $5,125 | 25.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 16 | 16 | $9,216 | $2,039 | 22.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 16 | 18 | $6,840 | $1,956 | 28.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $7,488 | $1,662 | 22.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $8,292 | $1,661 | 20.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 25 | $6,225 | $1,578 | 25.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 19 | 19 | $8,398 | $1,563 | 18.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 13 | 13 | $3,250 | $837.98 | 25.8% |
| 91200 | Measurement of liver stiffness | Facility | 2023 | 21 | 21 | $1,029 | $174.88 | 17.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 42 | 149 | $52,895 | $12,131 | 22.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 50 | 75 | $20,175 | $5,035 | 25.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 33 | 33 | $14,586 | $3,576 | 24.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 12 | 12 | $6,912 | $1,773 | 25.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $7,020 | $1,620 | 23.1% |
| 91200 | Measurement of liver stiffness | Facility | 2022 | 19 | 19 | $931.00 | $163.32 | 17.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 49 | 152 | $53,960 | $12,686 | 23.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 83 | 124 | $33,356 | $9,060 | 27.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 31 | 31 | $13,702 | $3,278 | 23.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 21 | 22 | $10,296 | $2,363 | 22.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 12 | $8,292 | $1,711 | 20.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $7,293 | $1,378 | 18.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 12 | 14 | $3,500 | $817.18 | 23.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 48 | 232 | $82,360 | $19,905 | 24.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 82 | 131 | $35,239 | $7,590 | 21.5% |
About Dr. Devina Bhasin, MD
Dr. Devina Bhasin, MD is a Internal Medicine healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1063607109.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Devina Bhasin, MD has received a total of $16,512 in payments from pharmaceutical and medical device companies, with $14,293 received in 2024. These payments were reported across 167 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($9,380).
As a Medicare-enrolled provider, Bhasin has provided services to 826 Medicare beneficiaries, totaling 1,447 services with total Medicare billing of $117,306. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist, Critical Care Medicine
- Location Atlanta, GA
- Active Since 09/12/2007
- Last Updated 02/06/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1063607109
Products in Payments
- Livdelzi (Drug) $13,355
- XIFAXAN (Drug) $649.52
- OCALIVA (Drug) $422.89
- MAVYRET (Drug) $227.05
- TheraSphere Y90 Glass Microspheres 10 GBq (Device) $152.23
- ULTOMIRIS (Biological) $127.44
- RESMETIROM (Drug) $126.35
- Cresemba (Drug) $100.23
- OCA (Drug) $60.41
- TERLIVAZ (Drug) $58.21
- IQIRVO (Drug) $52.10
- Viekira (Drug) $46.44
- ACTHAR (Biological) $42.75
- Renal - Acute (Device) $41.79
- LOKELMA (Drug) $41.15
- Nexavar (Drug) $38.23
- CUVRIOR (Drug) $37.95
- PREVNAR 20 (Biological) $37.08
- Bylvay (Drug) $34.63
- Mavyret (Drug) $32.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Atlanta
Dr. Nitin Gupta, M.d, M.D
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Dr. Zandraetta Tims-Cook, Md, Mph, MD, MPH
Internal Medicine — Payments: $648,799
Internal Medicine $648,799
Brian Pearlman, Md, MD
Internal Medicine — Payments: $588,483
Internal Medicine $588,483
Tracey Henry
Internal Medicine — Payments: $304,663
Internal Medicine $304,663
Michael Lloyd, Md, MD
Internal Medicine — Payments: $276,236
Internal Medicine $276,236
Mr. Robert Springer, M.d, M.D
Internal Medicine — Payments: $243,195
Internal Medicine $243,195